Heron Therapeutics, Inc. · NASDAQ:HRTX

Hensley Mark Earl exercised options for 125,000 Heron Therapeutics, Inc. shares (Form 4)

Traded May 6, 2026 · Filed May 7, 2026

On May 6, 2026, Hensley Mark Earl (Chief Operating Officer) exercised options for 125,000 Heron Therapeutics, Inc. shares, leaving 136,770 shares. Filed May 7, 2026 (Form 4).

Options exercised
125,000 shares
Holding after
136,770 shares
Trading plan
No
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 6, 2026Common StockOption exercise125,000136,770Direct

Source

View original at SEC

Related